iNKT

BIOLOGICAL2 trials

Sponsors

Beth Israel Deaconess Medical Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Conditions

Malignant MelanomaPancreatic Cancer

Phase 1

In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer

CompletedNCT00631072

Beth Israel Deaconess Medical CenterMalignant Melanoma

Start: 2008-02-29End: 2015-04-30Updated: 2017-06-09

Unknown Phase

A Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Allogeneic iNKT Cell Infusion in Subjects With Advanced Pancreatic Cancer

Not yet recruitingNCT07055568

Shanghai General Hospital, Shanghai Jiao Tong University School of MedicinePancreatic Cancer

Start: 2025-09-30End: 2028-01-30Target: 18Updated: 2025-07-09